Guillaume Manson

5PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 08, 2026
Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

|Mar 19, 2024
Impact of diagnostic investigations in the management of CAR T-cell-associated neurotoxicity.

Matteo Mauget, Sophie Lemercier, Quentin Quelven

|Apr 21, 2022
Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA).

Guillaume Manson, Charles Herbaux, Jean-Marc Schiano

|Mar 28, 2022
Interpretation of 2-[18F]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors.

Guillaume Manson, Amaeshi Chukwunonye Lemchukwu, Fatima-Zohra Mokrane

|Apr 15, 2020
Performance of CT Compared with 18F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma.

Fatima-Zohra Mokrane, Aiping Chen, Lawrence H Schwartz

Pageof 1

Frequent Collaborators

2 joint publications

Aspasia Stamatoullas

2 joint publications

Alain Delmer

1 joint publications

Fatima-Zohra Mokrane

1 joint publications

Aiping Chen